Noelle Frey, MD, a hematologist-oncologist at Penn Medicine and the Abramson Cancer Center, presents a summary of approaches to the myelodysplastic syndromes with a focus upon improved prognosis and the application of novel drug therapies.

Related Links

• Enrolling Clinical Trials: Umbilical Cord Blood Transplantation vs Haploidentical Transplantation for Patients with Hematological Malignancies